Luoxin Pharmaceutical: Report for the third quarter of 2024
Luoxin Pharmaceutical: Announcement of Resolutions of the 17th Meeting of the Fifth Board of Directors
Luoxin Pharmaceutical: Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors
Luoxin Pharmaceutical: Announcement on providing guarantees for holding subsidiaries to carry out financial leasing business
Luoxin Pharmaceutical: Announcement on obtaining a drug registration certificate for the new indications of tigoracin tablets
Luoxin Pharmaceutical: Luoxin Pharmaceutical Group Co., Ltd. 2024 Employee Stock Ownership Plan
Luoxin Pharmaceutical: Legal Opinion of the Shanghai Branch of Beijing King & Wood Mallesons on the 2024 Second Extraordinary General Meeting of Shareholders of Luoxin Pharmaceutical Group Co., Ltd.
Luoxin Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Luoxin Pharmaceutical: Legal Opinion of the Shanghai Branch of Beijing King & Wood Mallesons on the 2024 Employee Stock Ownership Plan (Draft) of Luoxin Pharmaceutical Group Co., Ltd.
Luo Xin Pharmaceutical: Simplified Equity Change Report (2)
Luo Xin Pharmaceutical: Simplified Equity Change Report (1)
Luoxin Pharmaceutical: An indicative announcement on changes in shareholders\' total shareholders\' agreement to transfer the company\'s shares and equity
Luoxin Pharmaceutical: 2024 Employee Stock Ownership Plan (Draft) Summary
Luoxin Pharmaceutical: 2024 Employee Stock Ownership Plan Management Measures
Luoxin Pharmaceutical: Supervisory Board\'s Audit Opinions on Matters Related to the Company\'s 2024 Employee Stock Ownership Plan
Luoxin Pharmaceutical: Announcement of Resolutions of the 16th Meeting of the Fifth Board of Directors
Luoxin Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Luoxin Pharmaceutical: Announcement of Resolutions of the 13th Meeting of the Fifth Board of Supervisors
Luoxin Pharmaceutical: Board of Directors Compliance Statement on the Company\'s 2024 Employee Stock Ownership Plan (Draft)
Luoxin Pharmaceutical: Announcement on providing guarantees for holding subsidiaries
No Data
No Data